Product Information
CELECOXIB 50 MG CAPSULE is a generic product labeled by Actavis Pharma, Inc., priced at $0.0914 per EA under NDC 00591398260. Its NADAC has been published 568 times since May 20, 2015.
FDA first approved this application on Feb 11, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591398260
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CELECOXIBApproval Type
Generic (ANDA)
FDA Application
ANDA200562FDA Approved
2/11/2015
TE Code
AB
On Market Since
3/12/2015
Pharmacological Classes
Price Statistics
The NADAC for CELECOXIB 50 MG CAPSULE has been published 568 times since May 20, 2015, and over the history we have for it it has declined 83.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0914 per EA |
|---|---|
| All-time high | $0.5704 (Jul 15, 2015) |
| All-time low | $0.0492 (Nov 20, 2024) |
| 52-week high | $0.1073 |
| 52-week low | $0.0817 |
| Median price | $0.1822 |
| Average price | $0.2176 |
| Largest weekly change | +128.0% (Jan 19, 2022) |
| Weeks tracked | 568 |
| Tracking since | May 20, 2015 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Actavis Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Celecoxib market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CELECOXIB 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CELECOXIB 50 MG CAPSULE, manufactured by Actavis Pharma, Inc., is $0.0914 per EA (NDC 00591398260), effective Sep 30, 2026.
How has the price of CELECOXIB 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CELECOXIB 50 MG CAPSULE has declined 83.9%. It has been tracked across 568 weekly CMS publications since May 20, 2015.
What are the highest and lowest recorded NADAC prices for CELECOXIB 50 MG CAPSULE?
Since May 20, 2015, the NADAC for CELECOXIB 50 MG CAPSULE has ranged from a low of $0.0492 (Nov 20, 2024) to a high of $0.5704 (Jul 15, 2015), with a median of $0.1822 per EA.
Are there cheaper alternatives to CELECOXIB 50 MG CAPSULE?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CELECOXIB 50 MG CAPSULE, is $0.0883 per EA — about 3% below CELECOXIB 50 MG CAPSULE.
Who manufactures CELECOXIB 50 MG CAPSULE?
CELECOXIB 50 MG CAPSULE (NDC 00591398260) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.